{
    "clinical_study": {
        "@rank": "85787", 
        "acronym": "SARIL-RA-EASY", 
        "arm_group": [
            {
                "arm_group_label": "Sarilumab SAR153191 (REGN88) via AID - Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "A single subcutaneous injection of Dose 1 every two weeks self-administered via auto-injector (AID)"
            }, 
            {
                "arm_group_label": "Sarilumab SAR153191 (REGN88) via PFS - Dose 1", 
                "arm_group_type": "Experimental", 
                "description": "A single subcutaneous injection of Dose 1 every two weeks self-administered via pre-filled syringe (PFS)"
            }, 
            {
                "arm_group_label": "Sarilumab SAR153191 (REGN88) via AID - Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "A single subcutaneous injection of Dose 2 every two weeks self-administered via auto-injector (AID)"
            }, 
            {
                "arm_group_label": "Sarilumab SAR153191 (REGN88) via PFS  Dose 2", 
                "arm_group_type": "Experimental", 
                "description": "A single subcutaneous injection of Dose 2 every two weeks self administered via prefilled syringe (PFS)"
            }
        ], 
        "brief_summary": {
            "textblock": "Primary Objective:\n\n      To collect real-use data of the sarilumab auto-injector used by rheumatoid arthritis (RA)\n      patients.\n\n      Secondary Objective:\n\n      To compare the pharmacokinetic (PK) exposure of sarilumab administered by AID versus\n      prefilled syringes (PFS)."
        }, 
        "brief_title": "To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "Total study duration up to 74 weeks: screening up to 4 weeks, AID assessment phase 12 weeks,\n      extension phase 52 weeks, post-treatment follow-up of 6 weeks.\n\n      For patients not entering the extension phase, total study duration up to 22 weeks\n      (screening, AID assessment phase and follow-up)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Diagnosis of rheumatoid arthritis (RA), \u22653 months disease duration\n\n          -  Patient willing and able to self-inject\n\n          -  Continuous treatment with 1 or a combination of nonbiologic DMARDs (except\n             leflunomide in combination with methotrexate)\n\n          -  Moderate-to-severely active RA\n\n        Exclusion criteria:\n\n          -  Patients<18  years\n\n          -  Prior treatment with anti-interleukin 6 (IL-6) or IL-6 receptor (IL-6R) antagonists\n\n          -  Treatment with tumor necrosis factor (TNF) antagonists\n\n          -  Treatment with RA-directed biologic agents other than with a TNF-\u03b1 antagonist\n             mechanism as follows: Anakinra, Abatacept, Rituximab or other cell-depleting agent\n\n          -  Prior treatment with a Janus kinase inhibitor\n\n        The above information is not intended to contain all considerations relevant to a\n        patient's potential participation in a clinical trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02057250", 
            "org_study_id": "MSC12665", 
            "secondary_id": [
                "2012-004339-21", 
                "U1111-1130-9931"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Sarilumab SAR153191 (REGN88) via AID - Dose 1", 
                    "Sarilumab SAR153191 (REGN88) via PFS - Dose 1", 
                    "Sarilumab SAR153191 (REGN88) via AID - Dose 2", 
                    "Sarilumab SAR153191 (REGN88) via PFS  Dose 2"
                ], 
                "description": "Pharmaceutical form:solution Route of administration: subcutaneous", 
                "intervention_name": "sarilumab SAR153191 (REGN88)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Sarilumab SAR153191 (REGN88) via AID - Dose 1", 
                    "Sarilumab SAR153191 (REGN88) via AID - Dose 2"
                ], 
                "intervention_name": "Auto-injector (AID)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Sarilumab SAR153191 (REGN88) via PFS - Dose 1", 
                    "Sarilumab SAR153191 (REGN88) via PFS  Dose 2"
                ], 
                "intervention_name": "Pre-filled Syringe (PFS)", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Peoria", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85381"
                    }, 
                    "name": "Investigational Site Number 840221"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roseville", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "95661"
                    }, 
                    "name": "Investigational Site Number 840226"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boulder", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80304"
                    }, 
                    "name": "Investigational Site Number 840223"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33185"
                    }, 
                    "name": "Investigational Site Number 840229"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32804"
                    }, 
                    "name": "Investigational Site Number 840236"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Harbor", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34684"
                    }, 
                    "name": "Investigational Site Number 840155"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "South Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Investigational Site Number 840220"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hagerstown", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21740"
                    }, 
                    "name": "Investigational Site Number 840202"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lincoln", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68516"
                    }, 
                    "name": "Investigational Site Number 840112"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45219"
                    }, 
                    "name": "Investigational Site Number 840224"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73103"
                    }, 
                    "name": "Investigational Site Number 840002"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "74135"
                    }, 
                    "name": "Investigational Site Number 840065"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethlehem", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "18015"
                    }, 
                    "name": "Investigational Site Number 840010"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duncansville", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "16635"
                    }, 
                    "name": "Investigational Site Number 840009"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reading", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19611"
                    }, 
                    "name": "Investigational Site Number 840062"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78705"
                    }, 
                    "name": "Investigational Site Number 840038"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Carrollton", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75007"
                    }, 
                    "name": "Investigational Site Number 840230"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75231"
                    }, 
                    "name": "Investigational Site Number 840001"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79424"
                    }, 
                    "name": "Investigational Site Number 840069"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mesquite", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75150"
                    }, 
                    "name": "Investigational Site Number 840074"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plano", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75042"
                    }, 
                    "name": "Investigational Site Number 840237"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cap Town", 
                        "country": "South Africa", 
                        "zip": "7530"
                    }, 
                    "name": "Investigational Site Number 710050"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "zip": "7530"
                    }, 
                    "name": "Investigational Site Number 710007"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "zip": "7405"
                    }, 
                    "name": "Investigational Site Number 710011"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durban", 
                        "country": "South Africa", 
                        "zip": "4001"
                    }, 
                    "name": "Investigational Site Number 710003"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jhohannesburg", 
                        "country": "South Africa", 
                        "zip": "2013"
                    }, 
                    "name": "Investigational Site Number 710001"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Port Elizabeth", 
                        "country": "South Africa", 
                        "zip": "6045"
                    }, 
                    "name": "Investigational Site Number 710051"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "South Africa"
            ]
        }, 
        "number_of_arms": "4", 
        "official_title": "A Multicenter, Randomized, Open-Label, Parallel-Group Usability Study Of The Sarilumab Auto-Injector Device And A Prefilled Syringe In Patients With Moderate To Severe Active Rheumatoid Arthritis Who Are Candidates For Anti-IL6R Therapy", 
        "overall_contact": {
            "email": "Contact-Us@sanofi.com", 
            "last_name": "For site information, send an email with site number to"
        }, 
        "overall_official": {
            "affiliation": "Sanofi", 
            "last_name": "Clinical Sciences & Operations", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of validated AID-associated product technical failures (PTFs)", 
            "safety_issue": "No", 
            "time_frame": "Up to 12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02057250"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Pharmacokinetics (PK): Area Under the Concentration-Time Curve (AUC) of Sarilumab using the auto-injector (AID) versus the prefilled syringe (PFS)", 
            "safety_issue": "No", 
            "time_frame": "Up to 12 weeks (during the AID assessment phase)"
        }, 
        "source": "Sanofi", 
        "sponsors": {
            "collaborator": {
                "agency": "Regeneron Pharmaceuticals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}